Ghent university spin-off looks to produce personalized cancer therapies safer, cheaper, and faster 07-Dec-2021 By Jane Byrne Trince, a spin-off of Ghent University (UGent) that is focused on advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo, has raised €4m (US$4.5m) from investors.